The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L- arginine

doi:10.1084/jem.179.2.651

This Article

Full Text (PDF, 1463K)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JEM

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Weinberg, J. B.

Articles by Gilkeson, G. S.

Search for Related Content

PubMed

PubMed Citation

Articles by Weinberg, J. B.

Articles by Gilkeson, G. S.

Pubmed/NCBI databases

Hazardous Substances DB
Gene	GEO Profiles
HomoloGene	UniGene
Compound via MeSH
Substance via MeSH
(L)-ARGININE
NITRIC OXIDE
Medline Plus Health Information
Arthritis
Autoimmune Diseases
Joint Disorders

Social Bookmarking

What's this?

ARTICLES

The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L- arginine

JB Weinberg, DL Granger, DS Pisetsky, MF Seldin, MA Misukonis, SN Mason, AM Pippen, P Ruiz, ER Wood and GS Gilkeson
Department of Medicine, Veterans Administration Medical Center, Durham, North Carolina 27705.

MRL-lpr/lpr mice spontaneously develop various manifestations of autoimmunity including an inflammatory arthropathy and immune complex glomerulonephritis. This study examines the role of nitric oxide, a molecule with proinflammatory actions, in the pathogenesis of MRL- lpr/lpr autoimmune disease. MRL-lpr/lpr mice excreted more urinary nitrite/nitrate (an in vivo marker of nitric oxide production) than did mice of normal strains and MRL-(+/+) and B6-lpr/lpr congenic strains. In addition, MRL-lpr/lpr peritoneal macrophages had an enhanced capacity to produce nitric oxide in vitro as well as increased nitric oxide synthase activity, and certain tissues from MRL-lpr/lpr mice had increased expression of inducible nitric oxide synthase (NOS) mRNA and increased amounts of material immunoreactive for inducible NOS. Oral administration of NG-monomethyl-L-arginine, a nitric oxide synthase inhibitor, prevented the development of glomerulonephritis and reduced the intensity of inflammatory arthritis in MRL-lpr/lpr mice. By using interspecific backcross mice, the gene for inducible NOS (Nosi) was mapped to mouse chromosome 11. This chromosomal localization was different from those loci that we have previously demonstrated to be linked to enhanced susceptibility to renal disease in an MRL-lpr/lpr cross. However, the chromosomal location of the NOS gene was consistent with an insulin-dependent diabetes locus identified in an analysis of nonobese diabetic (NOD) mice. These results suggest that elevated nitric oxide production could be important in the pathogenesis of autoimmunity, and that treatments to block the production of nitric oxide or block its effects might be valuable therapeutically.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Rodriguez, N., Lang, R., Wantia, N., Cirl, C., Ertl, T., Durr, S., Wagner, H., Miethke, T. (2008). Induction of iNOS by Chlamydophila pneumoniae requires MyD88-dependent activation of JNK. J. Leukoc. Biol. 84: 1585-1593 [Abstract] [Full Text]
Makimura, Y., Asai, Y., Sugiyama, A., Ogawa, T. (2007). Chemical structure and immunobiological activity of lipid A from Serratia marcescens LPS. J Med Microbiol 56: 1440-1446 [Abstract] [Full Text]
Pacher, P., Beckman, J. S., Liaudet, L. (2007). Nitric Oxide and Peroxynitrite in Health and Disease. Physiol. Rev. 87: 315-424 [Abstract] [Full Text]
Bobe, P., Bonardelle, D., Benihoud, K., Opolon, P., Chelbi-Alix, M. K. (2006). Arsenic trioxide: a promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice. Blood 108: 3967-3975 [Abstract] [Full Text]
Jimenez-Caliani, A. J., Jimenez-Jorge, S., Molinero, P., Fernandez-Santos, J. M., Martin-Lacave, I., Rubio, A., Guerrero, J. M., Osuna, C. (2006). Sex-Dependent Effect of Melatonin on Systemic Erythematosus Lupus Developed in Mrl/Mpj-Faslpr Mice: It Ameliorates the Disease Course in Females, whereas It Exacerbates It in Males. Endocrinology 147: 1717-1724 [Abstract] [Full Text]
Delgado Alves, J., Mason, L. J., Ames, P. R. J., Chen, P. P., Rauch, J., Levine, J. S., Subang, R., Isenberg, D. A. (2005). Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model. Rheumatology (Oxford) 44: 1238-1244 [Abstract] [Full Text]
Cherla, G., Jaimes, E. A. (2004). Role of L-Arginine in the Pathogenesis and Treatment of Renal Disease. J. Nutr. 134: 2801S-2806S [Abstract] [Full Text]
Ostendorf, T., van Roeyen, C., Westenfeld, R., Gawlik, A., Kitahara, M., de Heer, E., Kerjaschki, D., Floege, J., Ketteler, M. (2004). Inducible Nitric Oxide Synthase-Derived Nitric Oxide Promotes Glomerular Angiogenesis via Upregulation of Vascular Endothelial Growth Factor Receptors. J. Am. Soc. Nephrol. 15: 2307-2319 [Abstract] [Full Text]
Keller, C. C., Kremsner, P. G., Hittner, J. B., Misukonis, M. A., Weinberg, J. B., Perkins, D. J. (2004). Elevated Nitric Oxide Production in Children with Malarial Anemia: Hemozoin-Induced Nitric Oxide Synthase Type 2 Transcripts and Nitric Oxide in Blood Mononuclear Cells. Infect. Immun. 72: 4868-4873 [Abstract] [Full Text]
Jabs, D. A., Gerard, H. C., Wei, Y., Campbell, A. L., Hudson, A. P., Akpek, E. K., Lee, B., Prendergast, R. A., Whittum-Hudson, J. A. (2004). Inflammatory Mediators in Autoimmune Lacrimal Gland Disease in MRL/Mpj Mice. IOVS 45: 2293-2298 [Abstract] [Full Text]
Lee, Y H, Kim, H J, Rho, Y H, Choi, S J, Ji, J D, Song, G G (2004). Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with the development of lupus nephritis. Lupus 13: 188-191 [Abstract]
Dixit, K, Ali, R (2004). Role of nitric oxide modified DNA in the etiopathogenesis of systemic lupus erythematosus. Lupus 13: 95-100 [Abstract]
Lopez-Nevot, M. A., Ramal, L., Jimenez-Alonso, J., Martin, J. (2003). The inducible nitric oxide synthase promoter polymorphism does not confer susceptibility to systemic lupus erythematosus. Rheumatology (Oxford) 42: 113-116 [Abstract] [Full Text]
Ho, C. Y., Wong, C. K., Li, E. K., Tam, L. S., Lam, C. W. K. (2003). Elevated plasma concentrations of nitric oxide, soluble thrombomodulin and soluble vascular cell adhesion molecule-1 in patients with systemic lupus erythematosus. Rheumatology (Oxford) 42: 117-122 [Abstract] [Full Text]
McCartney-Francis, N. L., Wahl, S. M. (2002). Dysregulation of IFN-{gamma} Signaling Pathways in the Absence of TGF-{beta}1. J. Immunol. 169: 5941-5947 [Abstract] [Full Text]
Feng, X., Guo, Z., Nourbakhsh, M., Hauser, H., Ganster, R., Shao, L., Geller, D. A. (2002). Identification of a negative response element in the human inducible nitric-oxide synthase (hiNOS) promoter: The role of NF-kappa B-repressing factor (NRF) in basal repression of the hiNOS gene. Proc. Natl. Acad. Sci. USA 99: 14212-14217 [Abstract] [Full Text]
Ohtsuka, M., Konno, F., Honda, H., Oikawa, T., Ishikawa, M., Iwase, N., Isomae, K., Ishii, F., Hemmi, H., Sato, S. (2002). PPA250 [3-(2,4-Difluorophenyl)-6-{2-[4-(1H-imidazol-1-ylmethyl) Phenoxy]ethoxy}-2-phenylpyridine], a Novel Orally Effective Inhibitor of the Dimerization of Inducible Nitric-Oxide Synthase, Exhibits an Anti-Inflammatory Effect in Animal Models of Chronic Arthritis. J. Pharmacol. Exp. Ther. 303: 52-57 [Abstract] [Full Text]
Boyle, J. J., Weissberg, P. L., Bennett, M. R. (2002). Human Macrophage-Induced Vascular Smooth Muscle Cell Apoptosis Requires NO Enhancement of Fas/Fas-L Interactions. Arterioscler. Thromb. Vasc. Bio. 22: 1624-1630 [Abstract] [Full Text]
Virag, L., Szabo, C. (2002). The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors. Pharmacol. Rev. 54: 375-429 [Abstract] [Full Text]
Lui, S L, Tsang, R, Wong, D, Chan, K W, Chan, T M, Fung, P C W, Lai, K N (2002). Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupus-prone MRL/lpr mice. Lupus 11: 411-418 [Abstract]
Smith, J. B., Haynes, M. K. (2002). Rheumatoid Arthritis--A Molecular Understanding. ANN INTERN MED 136: 908-922 [Abstract] [Full Text]
Zhu, F.-G., Reich, C. F., Pisetsky, D. S. (2002). Inhibition of murine macrophage nitric oxide production by synthetic oligonucleotides. J. Leukoc. Biol. 71: 686-694 [Abstract] [Full Text]
Miyakawa, H., Sato, K., Shinbori, T., Okamoto, T., Gushima, Y., Fujiki, M., Suga, M. (2002). Effects of inducible nitric oxide synthase and xanthine oxidase inhibitors on SEB-induced interstitial pneumonia in mice. Eur Respir J 19: 447-457 [Abstract] [Full Text]
Ersoy, Y, Ozerol, E, Baysal, O, Temel, I, MacWalter, R S, Meral, U, Altay, Z E (2002). Serum nitrate and nitrite levels in patients with rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. Ann Rheum Dis 61: 76-78 [Abstract] [Full Text]
Ghosh, D. K., Misukonis, M. A., Reich, C., Pisetsky, D. S., Weinberg, J. B. (2001). Host Response to Infection: the Role of CpG DNA in Induction of Cyclooxygenase 2 and Nitric Oxide Synthase 2 in Murine Macrophages. Infect. Immun. 69: 7703-7710 [Abstract] [Full Text]
Esfandiari, E., McInnes, I. B., Lindop, G., Huang, F.-P., Field, M., Komai-Koma, M., Wei, X.-q., Liew, F. Y. (2001). A Proinflammatory Role of IL-18 in the Development of Spontaneous Autoimmune Disease. J. Immunol. 167: 5338-5347 [Abstract] [Full Text]
Dickie, P., Roberts, A., Lee, R. (2001). A defect in HIV-1 transgenic murine macrophages results in deficient nitric oxide production. J. Leukoc. Biol. 70: 592-600 [Abstract] [Full Text]
Khalil, M., Inaba, K., Steinman, R., Ravetch, J., Diamond, B. (2001). T Cell Studies in a Peptide-Induced Model of Systemic Lupus Erythematosus. J. Immunol. 166: 1667-1674 [Abstract] [Full Text]
Ozen, S., Usta, Y., Sahin-Erdemli, I., Orhan, D., Gumusel, B., Yang, B., Gursoy, Y., Tulunay, O., Dalkara, T., Bakkaloglu, A., El-Nahas, M. (2001). Association of nitric oxide production and apoptosis in a model of experimental nephropathy. Nephrol Dial Transplant 16: 32-38 [Abstract] [Full Text]
Schwobel, J., Fischer, T., Lanz, B., Mohaupt, M. (2000). Angiotensin II receptor subtypes determine induced NO production in rat glomerular mesangial cells. Am. J. Physiol. Renal Physiol. 279: F1092-F1100 [Abstract] [Full Text]
Hesse, M., Cheever, A. W., Jankovic, D., Wynn, T. A. (2000). NOS-2 Mediates the Protective Anti-Inflammatory and Antifibrotic Effects of the Th1-Inducing Adjuvant, IL-12, in a Th2 Model of Granulomatous Disease. Am. J. Pathol. 157: 945-955 [Abstract] [Full Text]
Hoffmann, K. F., Cheever, A. W., Wynn, T. A. (2000). IL-10 and the Dangers of Immune Polarization: Excessive Type 1 and Type 2 Cytokine Responses Induce Distinct Forms of Lethal Immunopathology in Murine Schistosomiasis. J. Immunol. 164: 6406-6416 [Abstract] [Full Text]
WALPEN, S., BECK, K.-F., EBERHARDT, W., APEL, M., CHATTERJEE, P. K., WRAY, G. M. H., THIEMERMANN, C., PFEILSCHIFTER, J. (2000). Downregulation of SPARC Expression Is Mediated by Nitric Oxide in Rat Mesangial Cells and during Endotoxemia in. J. Am. Soc. Nephrol. 11: 468-476 [Abstract] [Full Text]
Duffield, J. S., Erwig, L.-P., Wei, X.-q., Liew, F. Y., Rees, A. J., Savill, J. S. (2000). Activated Macrophages Direct Apoptosis and Suppress Mitosis of Mesangial Cells. J. Immunol. 164: 2110-2119 [Abstract] [Full Text]
Reilly, C. M., Oates, J. C., Cook, J. A., Morrow, J. D., Halushka, P. V., Gilkeson, G. S. (2000). Inhibition of Mesangial Cell Nitric Oxide in MRL/lpr Mice by Prostaglandin J2 and Proliferator Activation Receptor-{gamma} Agonists. J. Immunol. 164: 1498-1504 [Abstract] [Full Text]
Perkins, D. J., Kremsner, P. G., Schmid, D., Misukonis, M. A., Kelly, M. A., Weinberg, J. B. (1999). Blood Mononuclear Cell Nitric Oxide Production and Plasma Cytokine Levels in Healthy Gabonese Children with Prior Mild or Severe Malaria. Infect. Immun. 67: 4977-4981 [Abstract] [Full Text]
Bobe, P., Benihoud, K., Grandjon, D., Opolon, P., Pritchard, L. L., Huchet, R. (1999). Nitric Oxide Mediation of Active Immunosuppression Associated With Graft-Versus-Host Reaction. Blood 94: 1028-1037 [Abstract] [Full Text]
Ribas, G., Neville, M., Wixon, J. L., Cheng, J., Campbell, R. D. (1999). Genes Encoding Three New Members of the Leukocyte Antigen 6 Superfamily and a Novel Member of Ig Superfamily, Together with Genes Encoding the Regulatory Nuclear Chloride Ion Channel Protein (hRNCC) and a N{omega}-N{omega}-Dimethylarginine Dimethylaminohydrolase Homologue, Are Found in a 30-kb Segment of the MHC Class III Region. J. Immunol. 163: 278-287 [Abstract] [Full Text]
Goulet, J. L., Griffiths, R. C., Ruiz, P., Spurney, R. F., Pisetsky, D. S., Koller, B. H., Coffman, T. M. (1999). Deficiency of 5-Lipoxygenase Abolishes Sex-Related Survival Differences in MRL-lpr/lpr Mice. J. Immunol. 163: 359-366 [Abstract] [Full Text]
Jun, C.-D., Oh, C.-D., Kwak, H.-J., Pae, H.-O., Yoo, J.-C., Choi, B.-M., Chun, J.-S., Park, R.-K., Chung, H.-T. (1999). Overexpression of Protein Kinase C Isoforms Protects RAW 264.7 Macrophages from Nitric Oxide-Induced Apoptosis: Involvement of c-Jun N-Terminal Kinase/Stress-Activated Protein Kinase, p38 Kinase, and CPP-32 Protease Pathways. J. Immunol. 162: 3395-3401 [Abstract] [Full Text]
Rosen, G., Sela, M. N., Naor, R., Halabi, A., Barak, V., Shapira, L. (1999). Activation of Murine Macrophages by Lipoprotein and Lipooligosaccharide of Treponema denticola. Infect. Immun. 67: 1180-1186 [Abstract] [Full Text]
Lysle, D. T., How, T. (1999). Endogenous Opioids Regulate the Expression of Inducible Nitric Oxide Synthase by Splenocytes. J. Pharmacol. Exp. Ther. 288: 502-508 [Abstract] [Full Text]
Theofilopoulos, A N (1998). Effector and predisposing genes in murine lupus. Lupus 7: 575-584 [Abstract]
Kuroiwa, T, Lee, E G (1998). Cellular interactions in the pathogenesis of lupus nephritis: The role of T cells and macrophages in the amplification of the inflammatory process in the kidney. Lupus 7: 597-603 [Abstract]
Brown, C. R., Reiner, S. L. (1998). Activation of Natural Killer Cells in Arthritis-Susceptible but Not Arthritis-Resistant Mouse Strains following Borrelia burgdorferi Infection. Infect. Immun. 66: 5208-5214 [Abstract] [Full Text]
Marks-Konczalik, J., Chu, S. C., Moss, J. (1998). Cytokine-mediated Transcriptional Induction of the Human Inducible Nitric Oxide Synthase Gene Requires Both Activator Protein 1�and Nuclear Factor kappa B-binding Sites. J. Biol. Chem. 273: 22201-22208 [Abstract] [Full Text]
Badger, A. M., Cook, M. N., Lark, M. W., Newman-Tarr, T. M., Swift, B. A., Nelson, A. H., Barone, F. C., Kumar, S. (1998). SB 203580 Inhibits p38 Mitogen-Activated Protein Kinase, Nitric Oxide Production, and Inducible Nitric Oxide Synthase in Bovine Cartilage-Derived Chondrocytes. J. Immunol. 161: 467-473 [Abstract] [Full Text]
Mohaupt, M. G., Fischer, T., Schwobel, J., Sterzel, R. B., Schulze-Lohoff, E. (1998). Activation of purinergic P2Y2 receptors inhibits inducible NO synthase in cultured rat mesangial cells. Am. J. Physiol. Renal Physiol. 275: F103-F110 [Abstract] [Full Text]
Bogdan, C. (1998). The Multiplex Function of Nitric Oxide in (Auto)immunity. JEM 187: 1361-1365 [Full Text]
Xu, X., Gong, H., Blinder, L., Shen, J., Williams, J. W., Chong, A. S.-F. (1997). Control of Lymphoproliferative and Autoimmune Disease in MRL-lpr/lpr Mice by Brequinar Sodium: Mechanisms of Action. J. Pharmacol. Exp. Ther. 283: 869-875 [Abstract] [Full Text]
Mannick, J. B., Miao, X. Q., Stamler, J. S. (1997). Nitric Oxide Inhibits Fas-induced Apoptosis. J. Biol. Chem. 272: 24125-24128 [Abstract] [Full Text]
Gilkeson, G. S., Mudgett, J. S., Seldin, M. F., Ruiz, P., Alexander, A. A., Misukonis, M. A., Pisetsky, D. S., Weinberg, J. B. (1997). Clinical and Serologic Manifestations of Autoimmune Disease in MRL-lpr/lpr Mice Lacking Nitric Oxide Synthase Type 2�. JEM 186: 365-373 [Abstract] [Full Text]
Wigand, R., Meyer, J., Busse, R., Hecker, M. (1997). Increased serum NG-hydroxy-L-arginine in patients with rheumatoid arthritis and systemic lupus erythematosus as an index of an increased nitric oxide synthase activity. Ann Rheum Dis 56: 330-332 [Abstract] [Full Text]
Tada, Y., Ho, A., Matsuyama, T., Mak, T. W. (1997). Reduced Incidence and Severity of Antigen-induced Autoimmune Diseases in Mice Lacking Interferon Regulatory Factor-1. JEM 185: 231-238 [Abstract] [Full Text]
MURRELL, G. A. C., DOLAN, M. M., JANG, D., SZABO, C., WARREN, R. F., HANNAFIN, J. A. (1996). Nitric Oxide: an Important Articular Free Radical. JBJS 78: 265-74 [Abstract] [Full Text]
Russell, M. E., Wallace, A. F., Wyner, L. R., Newell, J. B., Karnovsky, M. J. (1995). Upregulation and Modulation of Inducible Nitric Oxide Synthase in Rat Cardiac Allografts With Chronic Rejection and Transplant Arteriosclerosis. Circulation 92: 457-464 [Abstract] [Full Text]
Nagata, S, Golstein, P (1995). The Fas death factor. Science 267: 1449-1456 [Abstract]
Kurose, I., Wolf, R., Grisham, M. B., Aw, T. Y., Specian, R. D., Granger, D. N. (1995). Microvascular Responses to Inhibition of Nitric Oxide Production : Role of Active Oxidants. Circ. Res. 76: 30-39 [Abstract] [Full Text]